229 related articles for article (PubMed ID: 22498828)
21. A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations.
Drabent P; Mitri R; Le Naour G; Hermine O; Rossignol J; Molina TJ; Barete S; Fraitag S
Am J Dermatopathol; 2021 Jan; 43(1):35-41. PubMed ID: 32568831
[TBL] [Abstract][Full Text] [Related]
22. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
24. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
[TBL] [Abstract][Full Text] [Related]
25. [Molecular pathological analysis of neoplastic mast cells with regard to the actual WHO classification of mast cell neoplasias].
Sotlar K
Verh Dtsch Ges Pathol; 2006; 90():227-35. PubMed ID: 17867601
[TBL] [Abstract][Full Text] [Related]
26. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
27. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
28. Solitary mastocytoma presenting in an adult: report and literature review of adult-onset solitary cutaneous mastocytoma with recommendations for evaluation and treatment.
Cohen PR
Dermatol Pract Concept; 2016 Jul; 6(3):31-8. PubMed ID: 27648381
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
32. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
36. Mast cell sarcoma: clinical management.
Weiler CR; Butterfield J
Immunol Allergy Clin North Am; 2014 May; 34(2):423-32. PubMed ID: 24745684
[TBL] [Abstract][Full Text] [Related]
37. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
[TBL] [Abstract][Full Text] [Related]
39. Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
Vergara-de-la-Campa L; Torrado I; Recuero-Pradillo M; Torrelo A; Gironella M; Pardal E; Godoy AC; Matito A; Pérez-Hortet C; Mollejo M; Álvarez-Twöse I
J Dermatol; 2021 May; 48(5):657-660. PubMed ID: 33684229
[TBL] [Abstract][Full Text] [Related]
40. Proliferation of reactive and neoplastic human tissue mast cells. An immunohistochemical study using the antibody PC10 (anti-PCNA).
Horny HP; Schumacher U; McCullagh P; Wehrmann M; Roche WR; Kaiserling E
J Pathol; 1993 Jul; 170(3):265-70. PubMed ID: 7907655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
